on QUANTEL (EPA:QUA)
Lumibird: H1 2024 Revenues
Lumibird reported its financial results for the first half of 2024. Revenue increased by 15% compared to the same period in 2023. This growth was driven by strong performance in the medical sector. The industrial and scientific divisions also showed steady growth.
The company's EBITDA for H1 2024 reached €20 million, reflecting a notable improvement in operational efficiency. The net income amounted to €10 million, marking a significant rise from the previous year. These results were achieved despite challenging market conditions.
Lumibird remains optimistic about continued growth for the rest of the year. The company plans to expand its market reach and invest in new technologies to maintain its competitive edge. This includes enhancing its product offerings and strengthening customer relationships.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all QUANTEL news